OWS has set a target of beginning the delivery of an approved, safe and effective covid-19 vaccine by the end of the year as part of a broader strategy to accelerate the design, production and distribution of COVID 19 vaccines, therapeutic drugs and diagnostics. OWS is a partnership between the department of health and human services and the Department of Defense, which cooperates with private companies and other federal authorities and coordinates existing HHS-wide efforts, including the NIH Partnership for Accelerated Interventions and Vaccines (ACTIV), the NIH Rapid Acceleration of Diagnostics (RADx) initiative, and the work of the Biomedical Advanced Research and Development Authority within the HHS Office of the Assistant. The contract is the largest share that the United States has spent on a vaccine, while agreements with other vaccine producers are also expected to help finance development costs. This press release contains “forward-looking statements” from BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may contain information about BioNTech`s efforts to combat COVID-19, but not limited to this: the opening date of clinical trials with BNT162 and the likely publication of data from these clinical trials; The date of authorization or authorization for the use of an emergency physician; The potential for additional supply agreements with other legal systems or the COVAX facility; The potential safety and effectiveness of BNT162; BioNTech and Pfizer`s cooperation in developing a potential COVID-19 vaccine; and BioNTech`s ability to provide quantities of BNT162 to support clinical development and, if approved, market demand, including our production estimates for 2020 and 2021. All forward-looking statements contained in this press release are based on BioNTech`s current expectations and beliefs in future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and negatively from the results presented or implied in such forward-looking statements.
Us Agreement With Pfizer
Bu yazı Genel kategorisine gönderilmiş. Kalıcı bağlantıyı yer imlerinize ekleyin.